The worldwide limited availability of suitable corneal donor tissue has led to the development of alternatives, including keratoprostheses (Kpros) and tissue engineered (TE) constructs. Despite advances in bioscaffold design, there is yet to be a corneal equivalent that effectively mimics both the native tissue ultrastructure and biomechanical properties. Human decellularized corneas (DCs) could offer a safe, sustainable source of corneal tissue, increasing the donor pool and potentially reducing the risk of immune rejection after corneal graft surgery. Appropriate, human-specific, decellularization techniques and high-resolution, non-destructive analysis systems are required to ensure reproducible outputs can be achieved. If robust treatment and characterization processes can be developed, DCs could offer a supplement to the donor corneal pool, alongside superior cell culture systems for pharmacology, toxicology and drug discovery studies.
References
[1]
Huang, Y.-X.; Li, Q.-H. An active artificial cornea with the function of inducing new corneal tissue generation in vivo—A new approach to corneal tissue engineering. Biomed. Mater. 2007, 2, 121–125, doi:10.1088/1748-6041/2/3/S07.
[2]
Carlsson, D.J.; Li, F.; Shimmura, S.; Griffith, M. Bioengineered corneas: How close are we? Curr. Opin. Ophthalmol. 2003, 14, 192–197, doi:10.1097/00055735-200308000-00004.
Oliva, M.S.; Schottman, T.; Gulati, M. Turning the tide of corneal blindness. Indian. J. Othalmol. 2012, 60, 423–427, doi:10.4103/0301-4738.100540.
[5]
Keenan, T.D.L.; Carley, F.; Yeates, D.; Jones, M.N.A.; Rushton, S.; Goldacre, M.J. Trends in corneal graft surgery in the UK. Br. J. Ophthalmol. 2011, 95, 468–472, doi:10.1136/bjo.2010.182329.
[6]
Zhang, C.; Nie, X.; Hu, D.; Liu, Y.; Deng, Z.; Dong, R.; Zhang, Y.; Jin, Y. Survival and integration of tissue-engineered corneal stroma in a model of corneal ulcer. Cell Tissue Res. 2007, 329, 249–257, doi:10.1007/s00441-007-0419-1.
[7]
Wilkemeyer, I.; Pruss, A.; Kalus, U.; Schroeter, J. Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors. Cell Tissue Bank 2012, 13, 447–452, doi:10.1007/s10561-012-9326-0.
[8]
Khodadoust, A.A. The allograft rejection reaction: The leading cause of late failure of clinical corneal grafts. In Ciba foundation symposium 15—Corneal graft failure; Porter, R., Knight, D., Eds.; John Wiley & Sons, Ltd: Chichester, UK, 2008; pp. 151–167.
Ekser, B.; Ezzelarab, M.; Hara, H.; van der Windt, D.J.; Wijkstrom, M.; Bottino, R.; Trucco, M.; Cooper, D.K.C. Clinical xenotransplantation: The next medical revolution? Lancet 2012, 379, 672–683.
Shao, Y.; Yu, Y.; Pei, C.G.; Zhou, Q.; Liu, Q.P.; Tan, G.; Li, J.M.; Gao, G.P.; Yang, L. Evaluation of novel decellularizing corneal stroma for cornea tissue engineering applications. Int. J. Ophthalmol. 2012, 5, 415–418.
[13]
Stevenson, W.; Cheng, S.-F.; Emami-Naeini, P.; Hua, J.; Paschalis, E.I.; Dana, R.; Saban, D.R. Gamma-irradiation reduces the allogenicity of donor corneas. Invest. Ophthalmol. Vis. Sci. 2012, 53, 7151–7158, doi:10.1167/iovs.12-9609.
[14]
Fagerholm, P.; Lagali, N.S.; Merrett, K.; Jackson, W.B.; Munger, R.; Liu, Y.; Polarek, J.W.; S？derqvist, M.; Griffith, M. A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci. Transl. Med. 2010, 2, 46–61.
[15]
Pintucci, S.; Pintucci, F.; Cecconi, M.; Caiazza, S. New dacron tissue colonisable keratoprosthesis—Clinical-experience. Br. J. Ophthalmol. 1995, 79, 825–829, doi:10.1136/bjo.79.9.825.
[16]
Ruberti, J.W.; Zieske, J.D.; Trinkaus-Randall, V. Corneal-tissue replacement. In Principles of tissue engineering; Lanza, R.P., Langer, R., Vacanti, J., Eds.; Elsevier Academic Press: London, UK, 2007; Volume 3, pp. 1025–1047.
Eguchi, H.; Hicks, C.R.; Crawford, G.J.; Tan, D.T.; Sutton, G.R. Cataract surgery with the alphacor artificial cornea. J. Cataract. Refract. Surg. 2004, 30, 1486–1491.
[19]
Chirila, T.V. An overview of the development of artificial corneas with porous skirts and the use of phema for such an application. Biomaterials 2001, 22, 3311–3317, doi:10.1016/S0142-9612(01)00168-5.
[20]
Zerbe, B.L.; Belin, M.W.; Ciolino, J.B. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology 2006, 113, 1779–1784, doi:10.1016/j.ophtha.2006.05.015.
[21]
Pan, Z.; Sun, C.; Jie, Y.; Wang, N.; Wang, L. Wzs-pig is a potential donor alternative in corneal xenotransplantation. Xenotransplantation 2007, 14, 603–611, doi:10.1111/j.1399-3089.2007.00432.x.
[22]
Van Essen, T.H.; Lin, C.C.; Hussain, A.K.; Maas, S.; Lai, H.J.; Linnartz, H.; van den Berg, T.J.T.P.; Salvatori, D.C.F.; Luyten, G.P.M.; Jager, M.J. A fish scale-derived collagen matrix as artificial cornea in rats: Properties and potential. Invest. Ophthalmol. Vis. Sci. 2013, 7, 3224–3233.
[23]
Suuronen, E.J.; McLaughlin, C.R.; Stys, P.K.; Nakamura, M.; Munger, R.; Griffith, M. Functional innervation in tissue engineered models for in vitro study and testing purposes. Toxicol. Sci. 2004, 82, 525–533, doi:10.1093/toxsci/kfh270.
[24]
Ahearne, M.; Yang, Y.; Liu, K.K. Mechanical characterisation of hydrogels for tissue engineering applications. In Topics in Tissue Engineering; Ashammakhi, N., Reis, R.L., Chielini, F., Eds.; Kluwer Academic Publisher: Dordrecht, the Netherlands, 2008; Volume 4.
[25]
Allan, B. Artificial corneas—Risks of complications are high now, but better materials are on the way. Bri. Med. J. 1999, 318, 821–822, doi:10.1136/bmj.318.7187.821.
Hicks, C.; Crawford, G.; Chirila, T.; Wiffen, S.; Vijayasekaran, S.; Lou, X.; Fitton, J.; Maley, M.; Clayton, A.; Dalton, P.; et al. Development and clinical assessment of an artificial cornea. Prog. Retin. Eye Res. 2000, 19, 149–170.
[28]
McLaughlin, C.R.; Tsai, R.J.F.; Latorre, M.A.; Griffith, M. Bioengineered corneas for transplantation and in vitro toxicology. Front. Biosci. 2009, 14, 3326–3337.
[29]
Orwin, E.J.; Hubel, A. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix. Tissue Eng. 2000, 6, 307–319, doi:10.1089/107632700418038.
[30]
Sandeman, S.R.; Lloyd, A.W.; Tighe, B.J.; Franklin, V.; Li, J.; Lydon, F.; Liu, C.S.C.; Mann, D.J.; James, S.E.; Martin, R. A model for the preliminary biological screening of potential keratoprosthetic biomaterials. Biomaterials 2003, 24, 4729–4739, doi:10.1016/S0142-9612(03)00370-3.
Wilson, S.L.; El Haj, A.J.; Yang, Y. Control of scar tissue formation in the cornea: Strategies in clinical and corneal tissue engineering. J. Funct. Biomat. 2012, 3, 642–687, doi:10.3390/jfb3030642.
[34]
Boneva, R.S.; Folks, T.M. Xenotransplantation and risks of zoonotic infections. Ann. Med. 2004, 36, 504–517, doi:10.1080/07853890410018826.
[35]
Larkin, D.F.P.; Williams, K.A. The host response in experimental corneal xenotransplantation. Eye 1995, 9, 254–260, doi:10.1038/eye.1995.49.
[36]
Griffith, M.; Osborne, R.; Munger, R.; Xiong, X.J.; Doillon, C.J.; Laycock, N.L.C.; Hakim, M.; Song, Y.; Watsky, M.A. Functional human corneal equivalents constructed from cell lines. Science 1999, 286, 2169–2172, doi:10.1126/science.286.5447.2169.
[37]
Vrana, N.E.; Builles, N.; Justin, V.; Bednarz, J.; Pellegrini, G.; Ferrari, B.; Damour, O.; Hulmes, D.J.S.; Hasirci, V. Development of a reconstructed cornea from collagen-chondroitin sulfate foams and human cell cultures. Invest. Ophthalmol. Vis. Sci. 2008, 49, 5325–5331, doi:10.1167/iovs.07-1599.
[38]
Roujeau, J.C.; Kelly, J.P.; Naldi, L.; Rzany, B.; Stern, R.S.; Anderson, T.; Auquier, A.; Bastujigarin, S.; Correia, O.; Locati, F.; et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Engl. J. Med. 1995, 333, 1600–1607, doi:10.1056/NEJM199512143332404.
[39]
Torbet, J.; Malbouyres, M.; Builles, N.; Justin, V.; Roulet, M.; Damour, O.; Oldberg, A.; Ruggieo, F.; Hulmes, D.J.S. Orthogonal scaffold of magnetically aligned collagen lamellae for corneal stroma reconstruction. Biomaterials 2007, 28, 4268–4276, doi:10.1016/j.biomaterials.2007.05.024.
[40]
Boote, C.; Dennis, S.; Huang, Y.F.; Quantock, A.J.; Meek, K.M. Lamellar orientation in human cornea in relation to mechanical properties. J. Struct. Biol. 2005, 149, 1–6, doi:10.1016/j.jsb.2004.08.009.
[41]
Crapo, P.M.; Gilbert, T.W.; Badylak, S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32, 3233–3243, doi:10.1016/j.biomaterials.2011.01.057.
[42]
Gilbert, T.W.; Sellaro, T.L.; Badylak, S.F. Decellularization of tissues and organs. Biomaterials 2006, 27, 3675–3683.
[43]
Tegtmeyer, S.; Papantoniou, I.; Muller-Goymann, C.C. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. Eur. J. Pharm. Biopharm. 2001, 51, 119–125.
[44]
Xu, Y.-G.; Xu, Y.-S.; Huang, C.; Feng, Y.; Li, Y.; Wang, W. Development of a rabbit corneal equivalent using an acellular corneal matrix of a porcine substrate. Mol. Vis. 2008, 14, 2180–2189.
[45]
Chen, W.; Lin, Y.; Zhang, X.; Wang, L.; Liu, M.; Liu, J.; Ye, Y.; Sun, L.; Ma, H.; Qu, J. Comparison of fresh corneal tissue versus glycerin-cryopreserved corneal tissue in deep anterior lamellar keratoplasty. Invest. Ophthalmol. Vis. Sci. 2010, 51, 775–781, doi:10.1167/iovs.09-3422.
[46]
Choi, J.S.; Williams, J.K.; Greven, M.; Walter, K.A.; Laber, P.W.; Khang, G.; Soker, S. Bioengineering endothelialized neo-corneas using donor-derived corneal endothelial cells and decellularized corneal stroma. Biomaterials 2010, 31, 6738–6745, doi:10.1016/j.biomaterials.2010.05.020.
[47]
Bayyoud, T.; Thaler, S.; Hofmann, J.; Maurus, C.; Spitzer, M.S.; Bartz-Schmidt, K.U.; Szurman, P.; Yoeruek, E. Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells. Curr. Eye. Res. 2012, 37, 179–186, doi:10.3109/02713683.2011.644382.
[48]
Badylak, S.F. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol. 2004, 12, 367–377, doi:10.1016/j.trim.2003.12.016.
[49]
Lakshman, N.; Petroll, W.M. Growth factor regulation of corneal keratocyte mechanical phenotypes in 3D collagen matrices. Invest. Ophthalmol. Vis. Sci. 2012, 53, 1077–1086, doi:10.1167/iovs.11-8609.
[50]
Imanishi, J.; Kamiyama, K.; Iguchi, I.; Kita, M.; Sotozono, C.; Kinoshita, S. Growth factors: Importance in wound healing and maintenance of transparency of the cornea. Prog. Retin. Eye Res. 2000, 19, 113–129.
[51]
Klenkler, B.; Sheardown, H. Growth factors in the anterior segment: Role in tissue maintenance, wound healing and ocular pathology. Exp. Eye Res. 2004, 79, 677–688, doi:10.1016/j.exer.2004.07.008.
[52]
Karamichos, D.; Hutcheon, A.E.K.; Zieske, J.D. Transforming growth factor-beta 3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J. Tissue Eng. Regen. Med. 2011, 5, 228–238, doi:10.1002/term.429.
[53]
Bussolino, F.; Direnzo, M.F.; Ziche, M.; Bocchietto, E.; Olivero, M.; Naldini, L.; Gaudino, G.; Tamagnone, L.; Coffer, A.; Comoglio, P.M. Hepatocyte growth-factor is a potent angiogenic factor which stimulates endothelial-cell motility and growth. J. Cell Biol. 1992, 119, 629–641, doi:10.1083/jcb.119.3.629.
[54]
NHS UK transplant registry. Available online: http://www.organdonation.nhs.uk/ (accessed on 4 February 2013).
[55]
Lynch, A.P.; Ahearne, M. Strategies for developing decellularized corneal scaffolds. Exp. Eye Res. 2012, 108, 42–47, doi:10.1016/j.exer.2012.12.012.
[56]
Musselmann, K.; Kane, B.; Alexandrou, B.; Hassell, J.R. Stimulation of collagen synthesis by insulin and proteoglycan accumulation by ascorbate in bovine keratocytes in vitro. Invest. Ophthalmol. Vis. Sci. 2006, 47, 5260–5266, doi:10.1167/iovs.06-0612.
Meek, K.M.; Boote, C. The organization of collagen in the corneal stroma. Exp. Eye. Res. 2004, 78, 503–512, doi:10.1016/j.exer.2003.07.003.
[59]
Wray, L.S.; Orwin, E.J. Recreating the microenvironment of the native cornea for tissue engineering applications. Tissue Eng. Part A 2009, 15, 1463–1472, doi:10.1089/ten.tea.2008.0239.
[60]
Bron, A.J. The architecture of the corneal stroma. Br. J. Ophthalmol. 2001, 85, 379–381, doi:10.1136/bjo.85.4.379.
[61]
Du, L.; Wu, X. Development and characterization of a full-thickness acellular porcine cornea matrix for tissue engineering. Artif. Organs 2011, 35, 691–705, doi:10.1111/j.1525-1594.2010.01174.x.
[62]
Gonzalez-Andrades, M.; de la Cruz Cardona, J.; Ionescu, A.M.; Campos, A.; Del Mar Perez, M.; Alaminos, M. Generation of bioengineered corneas with decellularized xenografts and human keratocytes. Invest. Ophthalmol. Vis. Sci. 2011, 52, 215–222, doi:10.1167/iovs.09-4773.
[63]
Hashimoto, Y.; Funamoto, S.; Sasaki, S.; Honda, T.; Hattori, S.; Nam, K.; Kimura, T.; Mochizuki, M.; Fujisato, T.; Kobayashi, H.; et al. Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering. Biomaterials 2010, 31, 3941–3948, doi:10.1016/j.biomaterials.2010.01.122.
[64]
Oh, J.Y.; Kim, M.K.; Lee, H.J.; Ko, J.H.; Wee, W.R.; Lee, J.H. Processing porcine cornea for biomedical applications. Tissue Eng. Part C Methods 2009, 15, 635–645.
[65]
Pang, K.; Du, L.; Wu, X. A rabbit anterior cornea replacement derived from acellular porcine cornea matrix, epithelial cells and keratocytes. Biomaterials 2010, 31, 7257–7265, doi:10.1016/j.biomaterials.2010.05.066.
[66]
Sasaki, S.; Funamoto, S.; Hashimoto, Y.; Kimura, T.; Honda, T.; Hattori, S.; Kobayashi, H.; Kishida, A.; Mochizuki, M. In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol. Vis. 2009, 15, 2022–2028.
[67]
Shao, Y.; Quyang, L.; Zhou, Y.; Tang, J.; Tan, Y.; Liu, Q.; Lin, Z.; Yin, T.; Qiu, F.; Liu, Z. Preparation and physical properties of a novel biocompatible porcine corneal acellularized matrix. In Vitro Cell Dev. Biol. Anim. 2010, 46, 600–605, doi:10.1007/s11626-010-9328-9.
[68]
Wu, Z.; Zhou, Y.; Li, N.; Huang, M.; Duan, H.; Ge, J.; Xiang, P.; Wang, Z. The use of phospholipase a(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold. Biomaterials 2009, 30, 3513–3522, doi:10.1016/j.biomaterials.2009.03.003.
[69]
Yoeruek, E.; Bayyoud, T.; Maurus, C.; Hofmann, J.; Spitzer, M.S.; Bartz-Schmidt, K.-U.; Szurman, P. Decellularization of porcine corneas and repopulation with human corneal cells for tissue-engineered xenografts. Acta Ophthalmol. 2012, 90, 125–131.
[70]
Proulx, S.; Audet, C.; Uwamaliya, J.; Deschambeault, A.; Carrier, P.; Giasson, C.J.; Brunette, I.; Germain, L. Tissue engineering of feline corneal endothelium using a devitalized human cornea as carrier. Tiss. Eng. Part A 2009, 15, 1709–1718.
[71]
Li, N.; Wang, X.; Wan, P.; Huang, M.; Wu, Z.; Liang, X.; Liu, Y.; Ge, J.; Huang, J.; Wang, Z. Tectonic lamellar keratoplasty with acellular corneal stroma in high-risk corneal transplantation. Mol. Vis. 2011, 17, 1909–1917.
[72]
Shafiq, M.A.; Gemeinhart, R.A.; Yue, B.Y.; Djalilian, A.R. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng. Part C Methods 2012, 18, 340–348.
[73]
Huang, M.; Li, N.; Wu, Z.; Wan, P.; Liang, X.; Zhang, W.; Wang, X.; Li, C.; Xiao, J.; Zhou, Q.; et al. Using acellular porcine limbal stroma for rabbit limbal stem cell microenvironment reconstruction. Biomaterials 2011, 32, 7812–7821.
[74]
Xiao, J.; Duan, H.; Liu, Z.; Wu, Z.; Lan, Y.; Zhang, W.; Li, C.; Chen, F.; Zhou, Q.; Wang, X.; et al. Construction of the recellularized corneal stroma using porous acellular corneal scaffold. Biomaterials 2011, 32, 6962–6971, doi:10.1016/j.biomaterials.2011.05.084.
[75]
Yoeruek, E.; Bayyoud, T.; Maurus, C.; Hofmann, J.; Spitzer, M.S.; Bartz-Schmidt, K.-U.; Szurman, P. Reconstruction of corneal stroma with decellularized porcine xenografts in a rabbit model. Acta Ophthalmol. 2011, 90, 206–210.
[76]
Ponce Márquez, S.; Martínez, V.S.; McIntosh Ambrose, W.; Wang, J.; Gantxegui, N.G.; Schein, O.; Elisseeff, J. Decellularization of bovine corneas for tissue engineering applications. Acta biomat. 2009, 5, 1839–1847, doi:10.1016/j.actbio.2009.02.011.
[77]
Li, J.; Shi, S.; Zhang, X.; Ni, S.; Wang, Y.; Curcio, C.A.; Chen, W. Comparison of different methods of glycerol preservation for deep anterior lamellar keratoplasty eligible corneas. Invest. Ophthalmol.Vis. Sci. 2012, 53, 5675–5685, doi:10.1167/iovs.12-9936.
[78]
Dai, Y.; Chen, J.; Li, H.; Li, S.; Chen, J.; Ding, Y.; Wu, J.; Wang, C.; Tan, M. Characterizing the effects of VPA, VC and RCCS on rabbit keratocytes onto decellularized bovine cornea. PLoS One 2012, 7, 1–10.
[79]
Du, L.; Wu, X.; Pang, K.; Yang, Y. Histological evaluation and biomechanical characterisation of an acellular porcine cornea scaffold. Br. J. Ophthalmol. 2011, 95, 410–414, doi:10.1136/bjo.2008.142539.
[80]
Fu, Y.; Fan, X.; Chen, P.; Shao, C.; Lu, W. Reconstruction of a tissue-engineered cornea with porcine corneal acellular matrix as the scaffold. Cells Tissues Organs 2010, 191, 193–202, doi:10.1159/000235680.
[81]
Wang, F.; Wang, Z.; Sun, X.; Wang, F.; Xu, X.; Zhang, X. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest. Ophthalmol. Vis. Sci. 2004, 45, 3286–3290, doi:10.1167/iovs.04-0026.
[82]
Yang, M.; Chen, C.Z.; Wang, X.N.; Zhu, Y.B.; Gu, Y.J. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91, 354–361.
[83]
Gui, L.; Chan, S.A.; Breuer, C.K.; Niklason, L.E. Novel utilization of serum in tissue decellularization. Tissue Eng. Part C Methods 2010, 16, 173–184.
[84]
Klebe, R.J. Isolation of a collagen-dependent cell attachment factor. Nature 1974, 250, 248–251.
[85]
Gailit, J.; Ruoslahti, E. Regulation of the fibronectin receptor affinity by divalent cations. J. Biol. Chem. 1988, 263, 12927–12932.
[86]
Reing, J.E.; Brown, B.N.; Daly, K.A.; Freund, J.M.; Gilbert, T.W.; Hsiong, S.X.; Huber, A.; Kullas, K.E.; Tottey, S.; Wolf, M.T.; et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 2010, 31, 8626–8633, doi:10.1016/j.biomaterials.2010.07.083.
[87]
Meyer, S.R.; Chiu, B.; Churchill, T.A.; Zhu, L.; Lakey, J.R.; Ross, D.B. Comparison of aortic valve allograft decellularization techniques in the rat. J. Biomed. Mater. Res. A 2006, 79, 254–262.
[88]
Yang, B.; Zhang, Y.; Zhou, L.; Sun, Z.; Zheng, J.; Chen, Y.; Dai, Y. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng. Part C Methods 2010, 16, 1201–1211.
[89]
Dong, X.; Wei, X.; Yi, W.; Gu, C.; Kang, X.; Liu, Y.; Li, Q.; Yi, D. RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. J. Mater. Sci. Mater. Med. 2009, 20, 2327–2336, doi:10.1007/s10856-009-3791-4.
[90]
Baptista, P.M.; Siddiqui, M.M.; Lozier, G.; Rodriguez, S.R.; Atala, A.; Soker, S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011, 53, 604–617, doi:10.1002/hep.24067.
[91]
Badylak, S.; Liang, A.; Record, R.; Tullius, R.; Hodde, J. Endothelial cell adherence to small intestinal submucosa: An acellular bioscaffold. Biomaterials 1999, 20, 2257–2263.
[92]
Dejardin, L.M.; Arnoczky, S.P.; Clarke, R.B. Use of small intestinal submucosal implants for regeneration of large fascial defects: An experimental study in dogs. J. Biomed. Mater. Res. 1999, 46, 203–211.
[93]
Huang, Q.; Dawson, R.A.; Pegg, D.E.; Kearney, J.N.; Macneil, S. Use of peracetic acid to sterilize human donor skin for production of acellular dermal matrices for clinical use. Wound Repair Regen. 2004, 12, 276–287.
[94]
Prasertsung, I.; Kanokpanont, S.; Bunaprasert, T.; Thanakit, V.; Damrongsakkul, S. Development of acellular dermis from porcine skin using periodic pressurized technique. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 85, 210–219.
[95]
Jamur, M.C.; Oliver, C. Cell fixatives for immunostaining. Methods Mol. Biol. 2010, 588, 55–61, doi:10.1007/978-1-59745-324-0_8.
[96]
Suthipintawong, C.; Leong, A.S.; Vinyuvat, S. Immunostaining of cell preparations: A comparative evaluation of common fixatives and protocols. Diagn. Cytopathol. 1996, 15, 167–174, doi:10.1002/(SICI)1097-0339(199608)15:2<167::AID-DC17>3.0.CO;2-F.
[97]
King, J.H., Jr.; Mc, T.J.; Meryman, H.T. Preservation of corneas for lamellar keratoplasty: A simple method of chemical glycerine-dehydration. Trans. Am. Ophthalmol. Soc. 1961, 59, 194–201.
[98]
King, J.H., Jr.; Mc, T.J.; Meryman, H.T. A simple method of preservation of corneas for lamellar keratoplasty. Am. J. Ophthalmol. 1962, 53, 445–449.
[99]
King, J.H., Jr.; Townsend, W.M. The prolonged storage of donor corneas by glycerine dehydration. Trans. Am. Ophthalmol. Soc. 1984, 82, 106–110.
[100]
Cox, B.; Emili, A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. 2006, 1, 1872–1878, doi:10.1038/nprot.2006.273.
[101]
Giusti, S.; Bogetti, M.E.; Bonafina, A.; de Plazas, F.S. An improved method to obtain a soluble nuclear fraction from embryonic brain tissue. Neurochem. Res. 2009, 34, 2022–2029, doi:10.1007/s11064-009-9993-9.
[102]
Elder, B.D.; Kim, D.H.; Athanasiou, K.A. Developing an articular cartilage decellularization process toward facet joint cartilage replacement. Neurosurgery 2010, 66, 722–727, doi:10.1227/01.NEU.0000367616.49291.9F.
[103]
Xu, C.C.; Chan, R.W.; Tirunagari, N. A biodegradable, acellular xenogeneic scaffold for regeneration of the vocal fold lamina propria. Tissue Eng. 2007, 13, 551–566.
[104]
Nagata, S.; Hanayama, R.; Kawane, K. Autoimmunity and the clearance of dead cells. Cell 2010, 140, 619–630, doi:10.1016/j.cell.2010.02.014.
[105]
Brown, B.N.; Valentin, J.E.; Stewart-Akers, A.M.; McCabe, G.P.; Badylak, S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30, 1482–1491.
[106]
Keane, T.J.; Londono, R.; Turner, N.J.; Badylak, S.F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012, 33, 1771–1781.
[107]
Zheng, M.H.; Chen, J.; Kirilak, Y.; Willers, C.; Xu, J.; Wood, D. Porcine small intestine submucosa (sis) is not an acellular collagenous matrix and contains porcine DNA: Possible implications in human implantation. J. Biomed. Mater. Res. B Appl. Biomater. 2005, 73, 61–67.
[108]
Ju, C.; Gao, L.; Wu, X.; Pang, K. A human corneal endothelium equivalent constructed with acellular porcine corneal matrix. Indian J. Med. Res. 2012, 135, 887–894.
[109]
Liu, Z.; Ji, J.; Zhang, J.; Huang, C.; Meng, Z.; Qiu, W.; Li, X.; Wang, W. Corneal reinforcement using an acellular dermal matrix for an analysis of biocompatibility, mechanical properties, and transparency. Acta Biomater. 2012, 8, 3326–3332, doi:10.1016/j.actbio.2012.05.004.
[110]
Chen, R.H.; Kadner, A.; Mitchell, R.N.; Adams, D.H. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation. J. Surg. Res. 2000, 90, 119–125, doi:10.1006/jsre.2000.5864.
[111]
Galili, U.; Clark, M.R.; Shohet, S.B.; Buehler, J.; Macher, B.A. Evolutionary relationship between the natural anti-gal antibody and the gal alpha 1–3gal epitope in primates. Proc. Natl. Acad. Sci. USA 1987, 84, 1369–1373, doi:10.1073/pnas.84.5.1369.
[112]
Simon, P.; Kasimir, M.T.; Seebacher, G.; Weigel, G.; Ullrich, R.; Salzer-Muhar, U.; Rieder, E.; Wolner, E. Early failure of the tissue engineered porcine heart valve synergraft in pediatric patients. Eur. J Cardiothorac. Surg. 2003, 23, 1002–1006, doi:10.1016/S1010-7940(03)00094-0.
[113]
Daly, K.A.; Stewart-Akers, A.M.; Hara, H.; Ezzelarab, M.; Long, C.; Cordero, K.; Johnson, S.A.; Ayares, D.; Cooper, D.K.; Badylak, S.F. Effect of the alphagal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng. Part A 2009, 15, 3877–3888, doi:10.1089/ten.tea.2009.0089.
[114]
Vitova, A.; Kuffova, L.; Klaska, I.P.; Holan, V.; Cornall, R.J.; Forrester, J.V. The high-risk corneal regraft model: A justification for tissue matching in humans. Transpl. Int. 2013, 26, 453–461, doi:10.1111/tri.12055.
[115]
Streilein, J.W.; Arancibia-Caracamo, C.; Osawa, H. The role of minor histocompatibility alloantigens in penetrating keratoplasty. Dev. Ophthalmol. 2003, 36, 74–88.
[116]
Jenke, D. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products, safety considerations related to extractables and leachables. J. Pharm. Sci. 2007, 96, 2566–2581, doi:10.1002/jps.20984.
[117]
Teng, S.W.; Tan, H.Y.; Peng, J.L.; Lin, H.H.; Kim, K.H.; Lo, W.; Sun, Y.; Lin, W.C.; Lin, S.J.; Jee, S.H.; et al. Multiphoton autofluorescence and second-harmonic generation imaging of the ex vivo porcine eye. Invest. Ophthalmol. Vis. Sci. 2006, 47, 1216–1224, doi:10.1167/iovs.04-1520.
Jalbert, I.; Stapleton, F.; Papas, E.; Sweeney, D.F.; Coroneo, M. In vivo confocal microscopy of the human cornea. Br. J. Ophthalmol. 2003, 87, 225–236.
[121]
Erie, J.C.; McLaren, J.W.; Patel, S.V. Confocal microscopy in ophthalmology. Am. J. Ophthalmol. 2009, 148, 639–646.
[122]
Newton, R.H.; Haffegee, J.P.; Ho, M.W. Polarized light microscopy of weakly birefringent biological specimens. J. Microsc. 1995, 180, 127–130, doi:10.1111/j.1365-2818.1995.tb03667.x.
[123]
Patel, D.V.; McGhee, C.N. Contemporary in vivo confocal microscopy of the living human cornea using white light and laser scanning techniques: A major review. Clin. Exp. Ophthalmol. 2007, 35, 71–88.
[124]
Guthoff, R.F.; Zhivov, A.; Stachs, O. In vivo confocal microscopy, an inner vision of the cornea—A major review. Clin. Exp. Ophthalmol. 2009, 37, 100–117, doi:10.1111/j.1442-9071.2009.02016.x.
[125]
Meek, K.M.; Boote, C. The use of X-ray scattering techniques to quantify the orientation and distribution of collagen in the corneal stroma. Prog. Retin. Eye Res. 2009, 28, 369–392, doi:10.1016/j.preteyeres.2009.06.005.
[126]
Doughty, M.J.; Bergmanson, J.P. Resolution and reproducibility of measures of the diameter of small collagen fibrils by transmission electron microscopy-application to the rabbit corneal stroma. Micron 2005, 36, 331–343, doi:10.1016/j.micron.2005.01.003.
[127]
Akhtar, S. Effect of processing methods for transmission electron microscopy on corneal collagen fibrils diameter and spacing. Microsc. Res. Tech. 2012, 75, 1420–1424, doi:10.1002/jemt.22083.
[128]
Hayashi, S.; Osawa, T.; Tohyama, K. Comparative observations on corneas, with special reference to Bowman's layer and Descemet’s membrane in mammals and amphibians. J. Morphol. 2002, 254, 247–258, doi:10.1002/jmor.10030.
[129]
Gusnard, D.; Kirschner, R.H. Cell and organelle shrinkage during preparation for scanning electron microscopy: Effects of fixation, dehydration and critical point drying. J. Microsc. 1977, 110, 51–57, doi:10.1111/j.1365-2818.1977.tb00012.x.
[130]
Morishige, N.; Wahlert, A.J.; Kenney, M.C.; Brown, D.J.; Kawamoto, K.; Chikama, T.; Nishida, T.; Jester, J.V. Second-harmonic imaging microscopy of normal human and keratoconus cornea. Invest. Ophthalmol. Vis. Sci. 2007, 48, 1087–1094, doi:10.1167/iovs.06-1177.
[131]
Han, M.; Zickler, L.; Giese, G.; Walter, M.; Loesel, F.H.; Bille, J.F. Second-harmonic imaging of cornea after intrastromal femtosecond laser ablation. J. Biomed. Opt. 2004, 9, 760–766, doi:10.1117/1.1756919.
[132]
Zoumi, A.; Yeh, A.; Tromberg, B.J. Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescence. Proc. Natl. Acad. Sci. USA 2002, 99, 11014–11019, doi:10.1073/pnas.172368799.
[133]
Reinstein, D.Z.; Silverman, R.H.; Sutton, H.F.; Coleman, D.J. Very high-frequency ultrasound corneal analysis identifies anatomic correlates of optical complications of lamellar refractive surgery: Anatomic diagnosis in lamellar surgery. Ophthalmology 1999, 106, 474–482, doi:10.1016/S0161-6420(99)90105-7.
Denoyer, A.; Ossant, F.; Arbeille, B.; Fetissof, F.; Patat, F.; Pourcelot, L.; Pisella, P.J. Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug. Ophthalmic. Res. 2008, 40, 298–308, doi:10.1159/000134928.
[136]
Reinstein, D.Z.; Archer, T.J.; Gobbe, M.; Silverman, R.H.; Coleman, J. Epithelial thickness in the normal cornea: Three-dimensional display with artemis very high-frequency digital ultrasound. J. Refrac. Surg. 2008, 24, 571–581.
Bagnaninchi, P.O.; Yang, Y.; Zghoul, N.; Maffulli, N.; Wang, R.K.; El Haj, A.J. Chitosan microchannel scaffolds for tendon tissue engineering characterized using optical coherence tomography. Tissue Eng. 2007, 13, 323–331.
[139]
Yang, Y.; Dubois, A.; Qin, X.P.; Li, J.; El Haj, A.; Wang, R.K. Investigation of optical coherence tomography as an imaging modality in tissue engineering. Phys. Med. Biol. 2006, 51, 1649–1659.
[140]
Yang, Y.; Bagnaninchi, P.O.; Ahearne, M.; Wang, R.K.; Liu, K.-K. A novel optical coherence tomography-based micro-indentation technique for mechanical characterization of hydrogels. J. R. Soc. Interface 2007, 4, 1169–1173, doi:10.1098/rsif.2007.1044.
Maurice, D.M. The structure and transparency of the cornea. J. Physiol. 1957, 136, 263–286.
[143]
Daxer, A.; Fratzl, P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest. Ophthalmol. Vis. Sci. 1997, 38, 121–129.
[144]
Daxer, A.; Misof, K.; Grabner, B.; Ettl, A.; Fratzl, P. Collagen fibrils in the human corneal stroma: Structure and aging. Invest. Ophthalmol. Vis. Sci. 1998, 39, 644–648.
[145]
Yamamoto, S.; Hitomi, J.; Sawaguchi, S.; Abe, H.; Shigeno, M.; Ushiki, T. Observation of human corneal and scleral collagen fibrils by atomic force microscopy. Jpn. J. Ophthalmol. 2002, 46, 496–501, doi:10.1016/S0021-5155(02)00558-0.
[146]
Ahearne, M. Mechanical Characterisation of Cornea and Corneal Stromal Equivalents. Ph.D. Dissertation, Keele University, Staffordshire, UK, 2007.
[147]
Glass, D.H.; Roberts, C.J.; Litsky, A.S.; Weber, P.A. A viscoelastic biomechanical model of the cornea describing the effect of viscosity and elasticity on hysteresis. Invest. Ophthalmol. Vis. Sci. 2008, 49, 3919–3926, doi:10.1167/iovs.07-1321.
[148]
Bao, F.; Jiang, L.; Wang, X.; Zhang, D.; Wang, Q.; Zeng, Y. Assessment of the ex vivo biomechanical properties of porcine cornea with inflation test for corneal xenotransplantation. J. Med. Eng. Technol. 2012, 36, 17–21, doi:10.3109/03091902.2011.629276.
[149]
Ahearne, M.; Siamantouras, E.; Yang, Y.; Liu, K.K. Mechanical characterization of biomimetic membranes by micro-shaft poking. J. R. Soc. Interface 2009, 6, 471–478, doi:10.1098/rsif.2008.0317.
[150]
Tsakalakos, T. The bulge test—A comparison of theory and experiment for isotropic and anisotropic films. Thin Solid Films 1981, 75, 293–305.
[151]
Elsheikh, A.; Anderson, K. Comparative study of corneal strip extensometry and inflation tests. J. R. Soc. Interface 2005, 2, 177–185, doi:10.1098/rsif.2005.0034.
[152]
Hoeltzel, D.A.; Altman, P.; Buzard, K.; Choe, K.I. Strip extensiometry for comparison of the mechanical response of bovine, rabbit, and human corneas. J. Biomech. Eng. 1992, 114, 202–215, doi:10.1115/1.2891373.
[153]
Boyce, B.L.; Grazier, J.M.; Jones, R.E.; Nguyen, T.D. Full-field deformation of bovine cornea under constrained inflation conditions. Biomaterials 2008, 29, 3896–3904, doi:10.1016/j.biomaterials.2008.06.011.
[154]
Krupa, I.; Nedelcev, T.; Racko, D.; Lacik, I. Mechanical properties of silica hydrogels prepared and aged at physiological conditions: Testing in the compression mode. J. Sol-Gel. Sci. Techn. 2010, 53, 107–114, doi:10.1007/s10971-009-2064-5.
[155]
Stammen, J.A.; Williams, S.; Ku, D.N.; Guldberg, R.E. Mechanical properties of a novel PVA hydrogel in shear and unconfined compression. Biomaterials 2001, 22, 799–806.
[156]
Korhonen, R.K.; Laasanen, M.S.; Toyras, J.; Rieppo, J.; Hirvonen, J.; Helminen, H.J.; Jurvelin, J.S. Comparison of the equilibrium response of articular cartilage in unconfined compression, confined compression and indentation. J. Biomech. 2002, 35, 903–909, doi:10.1016/S0021-9290(02)00052-0.
[157]
Koob, T.J.; Hernandez, D.J. Mechanical and thermal properties of novel polymerized NDGA—Gelatin hydrogels. Biomaterials 2003, 24, 1285–1292, doi:10.1016/S0142-9612(02)00465-9.
Smolek, M.K. Holographic-interferometry of intact and radially incised human eye-bank corneas. J. Cataract Refract. Surg. 1994, 20, 277–286.
[160]
Kasprzak, H.; Jaronski, J.; Forster, W.; Vonbally, G. Analysis of holographic interferograms of the expanded cornea after refractive surgery procedure. Proc. SPIE 1994, 2340, 480–486.
[161]
Kasprzak, H.; Forster, W.; Vonbally, G. Measurement of elastic-modulus of the bovine cornea by means of holographic-interferometry 1. Method and experiment. Optom. Vis. Sci. 1993, 70, 535–544, doi:10.1097/00006324-199307000-00004.
[162]
Maurice, D.M. Mechanics of the cornea. In The cornea: Transactions of the World Congress on the Cornea III; Cavanagh, H.D., Ed.; Raven Press Ltd: New York, NY, USA, 1988; Volume 8, p. 187.
[163]
Ahearne, M.; Yang, Y.; Then, K.Y.; Liu, K.K. Non-destructive mechanical characterisation of UVA/riboflavin crosslinked collagen hydrogels. Br. J. Ophthalmol. 2008, 92, 268–271, doi:10.1136/bjo.2007.130104.
[164]
Sullivan-Mee, M.; Billingsley, S.C.; Patel, A.D.; Halverson, K.D.; Alldredge, B.R.; Qualls, C. Ocular response analyzer in subjects with and without glaucoma. Optom. Vis. Sci. 2008, 85, 463–470, doi:10.1097/OPX.0b013e3181784673.
[165]
Abitbol, O.; Bouden, J.; Doan, S.; Hoang-Xuan, T.; Gatinel, D. Corneal hysteresis measured with the ocular response analyzer in normal and glaucomatous eyes. Acta Ophthalmol. 2010, 88, 116–119, doi:10.1111/j.1755-3768.2009.01554.x.
[166]
Zeng, Y.J.; Yang, J.; Huang, K.; Lee, Z.H.; Lee, X.Y. A comparison of biomechanical properties between human and porcine cornea. J. Biomech. 2001, 34, 533–537, doi:10.1016/S0021-9290(00)00219-0.
[167]
Ozdal, M.P.C.; Mansour, M.; Deschenes, J. Ultrasound biomicroscopic evaluation of the traumatized eyes. Eye 2003, 17, 467–472, doi:10.1038/sj.eye.6700382.
[168]
Urbak, S.F. Ultrasound biomicroscopy. III. Accuracy and agreement of measurements. Acta Ophthalmol. Scand. 1999, 77, 293–297.
[169]
Schneider, C.K.; Salmikangas, P.; Jilma, B.; Flamion, B.; Todorova, L.R.; Paphitou, A.; Haunerova, I.; Maimets, T.; Trouvin, J.H.; Flory, E.; et al. Challenges with advanced therapy medicinal products and how to meet them. Nat. Rev. Drug Discov. 2010, 9, 195–201.
[170]
Li, J.; Yu, L.; Deng, Z.; Wang, L.; Sun, L.; Ma, H.; Chen, W. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas. Am. J. Ophthalmol. 2011, 152, 762–770, doi:10.1016/j.ajo.2011.05.002.
[171]
Edelhauser, H.F. The balance between corneal transparency and edema the proctor lecture. Invest. Ophthalmol. Vis. Sci. 2006, 47, 1755–1767, doi:10.1167/iovs.05-1139.
[172]
Dua, H.S.; Shanmuganathan, V.A.; Powell-Richards, A.O.; Tighe, P.J.; Joseph, A. Limbal epithelial crypts: A novel anatomical structure and a putative limbal stem cell niche. Br. J. Ophthalmol. 2005, 89, 529–532.
[173]
Dua, H.S.; Azuara-Blanco, A. Limbal stem cells of the corneal epithelium. Surv. Ophthalmol. 2000, 44, 415–425, doi:10.1016/S0039-6257(00)00109-0.
[174]
Fernandes, M.; Sangwan, V.S.; Rao, S.K.; Basti, S.; Sridhar, M.S.; Bansal, A.K.; Dua, H.S. Limbal stem cell transplantation. Indian J. Ophthalmol. 2004, 52, 5–22.
[175]
Jenkins, C.; Tuft, S.; Liu, C.; Buckley, R. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy. Eye 1993, 7, 629–633, doi:10.1038/eye.1993.145.
[176]
Kim, H.S.; Jun Song, X.; de Paiva, C.S.; Chen, Z.; Pflugfelder, S.C.; Li, D.Q. Phenotypic characterization of human corneal epithelial cells expanded ex vivo from limbal explant and single cell cultures. Exp. Eye Res. 2004, 79, 41–49, doi:10.1016/j.exer.2004.02.015.
Lopez-Paniagua, M.; Nieto-Miguel, T.; de la Mata, A.; Galindo, S.; Herreras, J.M.; Corrales, R.M.; Calonge, M. Consecutive expansion of limbal epithelial stem cells from a single limbal biopsy. Curr. Eye Res. 2013, 38, 537–549, doi:10.3109/02713683.2013.767350.
[179]
Loureiro, R.R.; Cristovam, P.C.; Martins, C.M.; Covre, J.L.; Sobrinho, J.A.; Ricardo, J.R.; Hazarbassanov, R.M.; Hofling-Lima, A.L.; Belfort, R., Jr.; Nishi, M.; et al. Comparison of culture media for ex vivo cultivation of limbal epithelial progenitor cells. Mol. Vis. 2013, 19, 69–77.
[180]
Yu, D.; Chen, M.; Sun, X.; Ge, J. Differentiation of mouse induced pluripotent stem cells into corneal epithelial-like cells. Cell Biol. Int. 2013, 37, 87–94.
[181]
Hayashi, R.; Ishikawa, Y.; Ito, M.; Kageyama, T.; Takashiba, K.; Fujioka, T.; Tsujikawa, M.; Miyoshi, H.; Yamato, M.; Nakamura, Y.; et al. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. Plos One 2012, 7, 1–10.
[182]
Ahmed, N.; Vogel, B.; Rohde, E.; Strunk, D.; Grifka, J.; Schulz, M.B.; Grassel, S. CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells. Int. J. Mol. Med. 2006, 18, 233–240.
[183]
Homma, R.; Yoshikawa, H.; Takeno, M.; Kurokawa, M.S.; Masuda, C.; Takada, E.; Tsubota, K.; Ueno, S.; Suzuki, N. Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice. Invest. Ophthalmol. Vis. Sci. 2004, 45, 4320–4326, doi:10.1167/iovs.04-0044.
[184]
Notara, M.; Hernandez, D.; Mason, C.; Daniels, J.T. Characterization of the phenotype and functionality of corneal epithelial cells derived from mouse embryonic stem cells. Regen. Med. 2012, 7, 167–178, doi:10.2217/rme.11.117.
[185]
Gomes, J.A.; Geraldes Monteiro, B.; Melo, G.B.; Smith, R.L.; Cavenaghi Pereira da Silva, M.; Lizier, N.F.; Kerkis, A.; Cerruti, H.; Kerkis, I. Corneal reconstruction with tissue-engineered cell sheets composed of human immature dental pulp stem cells. Invest. Ophthalmol. Vis. Sci. 2010, 51, 1408–1414, doi:10.1167/iovs.09-4029.
[186]
Reza, H.M.; Ng, B.Y.; Gimeno, F.L.; Phan, T.T.; Ang, L.P. Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration. Stem Cell Rev. 2011, 7, 935–947.
[187]
Jiang, T.S.; Cai, L.; Ji, W.Y.; Hui, Y.N.; Wang, Y.S.; Hu, D.; Zhu, J. Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol. Vis. 2010, 16, 1304–1316.
[188]
Hoar, R.M. Embryology of the eye. Environ. Health Perspect. 1982, 44, 31–34, doi:10.1289/ehp.824431.
[189]
Forrester, J.V.; Dick, A.D.; McMenamin, P.G.; Roberts, F. The eye: Basic sciences in practice, 3rd ed. ed.; Saunders: Aberdeen, UK, 2008; p. 540.
[190]
West-Mays, J.A.; Dwivedi, D.J. The keratocyte: Corneal stromal cell with variable repair phenotypes. Int. J. Biochem. Cell Biol. 2006, 38, 1625–1631, doi:10.1016/j.biocel.2006.03.010.
[191]
Du, Y.; Funderburgh, M.L.; Mann, M.M.; SundarRaj, N.; Funderburgh, J.L. Multipotent stem cells in human corneal stroma. Stem Cells 2005, 23, 1266–1275, doi:10.1634/stemcells.2004-0256.
[192]
Poole, C.A.; Brookes, N.H.; Clover, G.M. Keratocyte networks visualised in the living cornea using vital dyes. J. Cell Sci. 1993, 106, 685–691.
[193]
Ueda, A.; Nishida, T.; Otori, T.; Fujita, H. Electron-microscopic studies on the presence of gap junctions between corneal fibroblasts in rabbits. Cell Tissue Res. 1987, 249, 473–475.
[194]
Marshall, G.E.; Konstas, A.G.; Lee, W.R. Immunogold fine structural localization of extracellular matrix components in aged human cornea. I. Types I-IV collagen and laminin. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229, 157–163, doi:10.1007/BF00170550.
[195]
Chakravarti, S.; Petroll, W.M.; Hassell, J.R.; Jester, J.V.; Lass, J.H.; Paul, J.; Birk, D.E. Corneal opacity in lumican-null mice: Defects in collagen fibril structure and packing in the posterior stroma. Invest. Ophthalmol. Vis. Sci. 2000, 41, 3365–3373.
[196]
Scott, J.E.; Thomlinson, A.M. The structure of interfibrillar proteoglycan bridges (shape modules’) in extracellular matrix of fibrous connective tissues and their stability in various chemical environments. J. Anat. 1998, 192, 391–405.
[197]
Nakamura, M.; Kimura, S.; Kobayashi, M.; Hirano, K.; Hoshino, T.; Awaya, S. Type VI collagen bound to collagen fibrils by chondroitin/dermatan sulfate glycosaminoglycan in mouse corneal stroma. Jpn. J. Ophthalmol. 1997, 41, 71–76, doi:10.1016/S0021-5155(97)00011-7.
[198]
Michelacci, Y.M. Collagens and proteoglycans of the corneal extracellular matrix. Braz. J. Med. Biol. Res. 2003, 36, 1037–1046, doi:10.1590/S0100-879X2003000800009.
[199]
Fini, M.E.; Stramer, B.M. How the cornea heals: Cornea-specific repair mechanisms affecting surgical outcomes. Cornea 2005, 24, 2–11, doi:10.1097/01.ico.0000178743.06340.2c.
[200]
Hassell, J.R.; Birk, D.E. The molecular basis of corneal transparency. Exp. Eye Res. 2010, 91, 326–335, doi:10.1016/j.exer.2010.06.021.
[201]
Jester, J.V.; Brown, D.; Pappa, A.; Vasiliou, V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering. Invest. Ophthalmol. Vis. Sci. 2012, 53, 770–778, doi:10.1167/iovs.11-9092.
[202]
Jester, J.V.; Moller-Pedersen, T.; Huang, J.; Sax, C.M.; Kays, W.T.; Cavangh, H.D.; Petroll, W.M.; Piatigorsky, J. The cellular basis of corneal transparency: Evidence for “corneal crystallins”. J. Cell Sci. 1999, 112, 613–622.
[203]
Sax, C.M.; Kays, W.T.; Salamon, C.; Chervenak, M.M.; Xu, Y.S.; Piatigorsky, J. Transketolase gene expression in the cornea is influenced by environmental factors and developmentally controlled events. Cornea 2000, 19, 833–841, doi:10.1097/00003226-200011000-00014.
[204]
Joseph, A.; Hossain, P.; Jham, S.; Jones, R.E.; Tighe, P.; McIntosh, R.S.; Dua, H.S. Expression of CD34 and l-selectin on human corneal keratocytes. Invest. Ophthalmol. Vis. Sci. 2003, 44, 4689–4692, doi:10.1167/iovs.02-0999.
[205]
Perrella, G.; Brusini, P.; Spelat, R.; Hossain, P.; Hopkinson, A.; Dua, H.S. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes. Br. J. Ophthalmol. 2007, 91, 94–99, doi:10.1136/bjo.2006.097352.
[206]
Fini, M.E. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog. Retin. Eye Res. 1999, 18, 529–551, doi:10.1016/S1350-9462(98)00033-0.
[207]
Beales, M.P.; Funderburgh, J.L.; Jester, J.V.; Hassell, J.R. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: Maintenance of the keratocyte phenotype in culture. Invest. Ophthalmol. Vis. Sci. 1999, 40, 1658–1663.
[208]
Masur, S.K.; Dewal, H.S.; Dinh, T.T.; Erenburg, I.; Petridou, S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. USA 1996, 93, 4219–4223.
[209]
Long, C.J.; Roth, M.R.; Tasheva, E.S.; Funderburgh, M.; Smit, R.; Conrad, G.W.; Funderburgh, J.L. Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes in vitro. J. Biol. Chem. 2000, 275, 13918–13923.
[210]
Ahearne, M.; Yang, Y.; El Haj, A.J.; Then, K.Y.; Liu, K.K. Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications. J. R. Soc. Interface 2005, 2, 455–463, doi:10.1098/rsif.2005.0065.
[211]
Barbaro, V.; Di Iorio, E.; Ferrari, S.; Bisceglia, L.; Ruzza, A.; De Luca, M.; Pellegrini, G. Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing. Invest. Ophthalmol. Vis. Sci. 2006, 47, 5243–5250.
[212]
Park, S.H.; Kim, K.W.; Chun, Y.S.; Kim, J.C. Human mesenchymal stem cells differentiate into keratocyte-like cells in keratocyte-conditioned medium. Exp. Eye Res. 2012, 101, 16–26, doi:10.1016/j.exer.2012.05.009.
Funderburgh, J.L.; Mann, M.M.; Funderburgh, M.L. Keratocyte phenotype mediates proteoglycan structure: A role for fibroblasts in corneal fibrosis. J. Biol. Chem. 2003, 278, 45629–45637, doi:10.1074/jbc.M303292200.
[216]
Helary, C.; Ovtracht, L.; Coulomb, B.; Godeau, G.; Giraud-Guille, M.M. Dense fibrillar collagen matrices: A model to study myofibroblast behaviour during wound healing. Biomaterials 2006, 27, 4443–4452.
Wilson, S.L.; Wimpenny, I.; Ahearne, M.; Rauz, S.; El Haj, A.J.; Yang, Y. Chemical and topographical effects on cell differentiation and matrix elasticity in a corneal stromal layer model. Adv. Func. Mater. 2012, 22, 3641–3649, doi:10.1002/adfm.201200655.
[219]
Ren, R.; Hutcheon, A.E.; Guo, X.Q.; Saeidi, N.; Melotti, S.A.; Ruberti, J.W.; Zieske, J.D.; Trinkaus-Randall, V. Human primary corneal fibroblasts synthesize and deposit proteoglycans in long-term 3-D cultures. Dev. Dyn. 2008, 237, 2705–2715.
[220]
Funderburgh, M.L.; Du, Y.; Mann, M.M.; SundarRaj, N.; Funderburgh, J.L. PAX6 expression identifies progenitor cells for corneal keratocytes. FASEB J. 2005, 19, 1371–1373.
[221]
Branch, M.J.; Hashmani, K.; Dhillon, P.; Jones, D.R.; Dua, H.S.; Hopkinson, A. Mesenchymal stem cells in the human corneal limbal stroma. Invest. Ophthalmol. Vis. Sci. 2012, 53, 5109–5166.
Samples, J.R.; Binder, P.S.; Nayak, S.K. Propagation of human corneal endothelium in vitro effect of growth factors. Exp. Eye Res. 1991, 52, 121–128, doi:10.1016/0014-4835(91)90252-A.
[229]
Engelmann, K.; Bednarz, J.; Valtink, M. Prospects for endothelial transplantation. Exp. Eye Res. 2004, 78, 573–578, doi:10.1016/S0014-4835(03)00209-4.
[230]
Engelmann, K.; Bohnke, M.; Friedl, P. Isolation and long-term cultivation of human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 1988, 29, 1656–1662.
[231]
Hempel, B.; Bednarz, J.; Engelmann, K. Use of a serum-free medium for long-term storage of human corneas. Influence on endothelial cell density and corneal metabolism. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239, 801–805, doi:10.1007/s004170100364.
Zhu, C.; Joyce, N.C. Proliferative response of corneal endothelial cells from young and older donors. Invest. Ophthalmol. Vis. Sci. 2004, 45, 1743–1751.
[234]
Peh, G.S.; Beuerman, R.W.; Colman, A.; Tan, D.T.; Mehta, J.S. Human corneal endothelial cell expansion for corneal endothelium transplantation: An overview. Transplantation 2011, 91, 811–819.
[235]
Whikehart, D.R.; Parikh, C.H.; Vaughn, A.V.; Mishler, K.; Edelhauser, H.F. Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol. Vis. 2005, 11, 816–824.
[236]
Yu, W.Y.; Sheridan, C.; Grierson, I.; Mason, S.; Kearns, V.; Lo, A.C.; Wong, D. Progenitors for the corneal endothelium and trabecular meshwork: A potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma. J. Biomed. Biotech. 2011, 2011, 1–13.
[237]
McGowan, S.L.; Edelhauser, H.F.; Pfister, R.R.; Whikehart, D.R. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol. Vis. 2007, 13, 1984–2000.
[238]
Joyce, N.C.; Harris, D.L.; Markov, V.; Zhang, Z.; Saitta, B. Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol. Vis. 2012, 18, 547–564.
[239]
Shao, C.; Fu, Y.; Lu, W.; Fan, X. Bone marrow-derived endothelial progenitor cells: A promising therapeutic alternative for corneal endothelial dysfunction. Cells Tissues Organs 2011, 193, 253–263, doi:10.1159/000319797.
[240]
Ju, C.; Zhang, K.; Wu, X. Derivation of corneal endothelial cell-like cells from rat neural crest cells in vitro. PLoS One 2012, 7, 1–7.
[241]
Hatou, S.; Yoshida, S.; Higa, K.; Miyashita, H.; Inagaki, E.; Okano, H.; Tsubota, K.; Shimmura, S. Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and wnt/beta-catenin signaling. Stem Cells Dev. 2013, 22, 828–839.
[242]
Griffith, M.; Jackson, W.B.; Lagali, N.; Merrett, K.; Li, F.; Fagerholm, P. Artificial corneas: A regenerative medicine approach. Eye 2009, 23, 1985–1989.
Jester, J.V.; Li, L.; Molai, A.; Maurer, J.K. Extent of initial corneal injury as a basis for alternative eye irritation tests. Toxicol. in Vitro 2001, 15, 115–130.
[245]
NC3Rs. Available online: http://www.nc3rs.org.uk/ (accessed on 27 March 2013).
[246]
European Parliment Council. Directive 2010/63/EU, The European parliment and of the council. Off. J. Eur. Union 2012, 53, 33–79.
[247]
Burton, A.B.G.; York, M.; Lawrence, R.S. The in vitro assessment of severe eye irritants. Food Cosmet. Toxicol. 1981, 19, 471–480, doi:10.1016/0015-6264(81)90452-1.
[248]
Prinsen, M.K. The chicken enucleated eye test (CEET): A practical (pre)screen for the assessment of eye irritation/corrosion potential of test materials. Food Chem. Toxicol. 1996, 34, 291–296, doi:10.1016/0278-6915(95)00115-8.
[249]
Reichl, S.; Muller-Goymann, C.C. Development of an organotypical cornea construct as an in vitro model for permeation studies. Ophthalmologe 2001, 98, 853–858.
[250]
Matsuda, S.; Hisama, M.; Shibayama, H.; Itou, N.; Iwaki, M. Application of the reconstructed rabbit corneal epithelium model to assess the in vitro eye irritancy test of chemicals. Yakugaku Zasshi 2009, 129, 1113–1120.
[251]
Reichl, S.; Muller-Goymann, C.C. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride. Int. J. Pharm. 2003, 250, 191–201, doi:10.1016/S0378-5173(02)00541-0.
[252]
Reichl, S.; Bednarz, J.; Muller-Goymann, C.C. Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br. J. Ophthalmol. 2004, 88, 560–565, doi:10.1136/bjo.2003.028225.
[253]
Mazzoleni, G.; Di Lorenzo, D.; Steimberg, N. Modelling tissues in 3D: The next future of pharmaco-toxicology and food research? Genes Nutr. 2009, 4, 13–22.
[254]
Reichl, S.; Dohring, S.; Bednarz, J.; Muller-Goymann, C.C. Human cornea construct HCC—An alternative for in vitro permeation studies? A comparison with human donor corneas. Eur. J. Pharm. Biopharm. 2005, 60, 305–308.
[255]
Sheasgreen, J.; Klausner, M.; Kandarova, H.; Ingalls, D. The mattek story—How the three rs principles led to 3D tissue success! Altern. Lab. Anim. 2009, 37, 611–622.
[256]
NIH. Available online: http://www.clinicaltrials.gov/ct2/results?term=acellular+cornea &Search=Search &Search=Search (accessed on 5 March 2013).
